SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-18-270139
Filing Date
2018-09-10
Accepted
2018-09-10 17:16:57
Documents
2
Period of Report
2018-09-10

Document Format Files

Seq Description Document Type Size
1 PRE 14A d600447dpre14a.htm PRE 14A 300600
2 GRAPHIC g600447snap1.jpg GRAPHIC 2735
  Complete submission text file 0001193125-18-270139.txt   305730
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-22873 | Film No.: 181063410
SIC: 2835 In Vitro & In Vivo Diagnostic Substances